Use of copper-cysteamine nanoparticles to simultaneously enable radiotherapy, oxidative therapy and immunotherapy for melanoma treatment

Signal Transduct Target Ther. 2020 May 15;5(1):58. doi: 10.1038/s41392-020-0156-4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Line, Tumor
  • Copper* / chemistry
  • Copper* / pharmacology
  • Cysteamine* / chemistry
  • Cysteamine* / pharmacology
  • Immunotherapy*
  • Melanoma, Experimental / immunology
  • Melanoma, Experimental / metabolism
  • Melanoma, Experimental / therapy*
  • Mice
  • Nanoparticles* / chemistry
  • Nanoparticles* / therapeutic use
  • Oxidative Stress* / drug effects
  • Oxidative Stress* / radiation effects

Substances

  • Cysteamine
  • Copper